The patent application was filed by Nantcell, Inc. for a coordinated multi-prong cancer therapy. It was filed on June 30, 2017 before being approved on Dec. 28, 2021.
Though patents are required for inventions and products, the granting of a patent is not a guarantee for success. Dennis Crouch, co-director of the Center for Intellectual Property & Entrepreneurship, said roughly 50 percent of patents expire prematurely due to costs.
There were 13 patents granted for Culver City inventors in December.
Longest patent application periods in Culver City for December
| Applicant Name | Days to be Granted |
|---|---|
| Nant Holdings IP, LLC | 1,642 |
| Nantcell, Inc. | 1,642 |
| Nant Holdings IP, LLC | 1,014 |
| Sony Pictures Entertainment, Inc. | 783 |
| Nant Holdings IP, LLC | 767 |
| Nanthealth, Inc. | 753 |
| NantOmics, LLC | 753 |
| Sony Pictures Entertainment, Inc. | 746 |
| Nant Holdings IP, LLC | 578 |
| Nant Holdings IP, LLC | 515 |
| Nantcell, Inc. | 319 |
| ImmunityBio, Inc. | 183 |
| Nant Holdings IP, LLC | 183 |
Alerts Sign-up